Intelligo

Private limited company · Bærum

ASCENSIA DIABETES CARE NORWAY AS

ActiveResearch and experimental development on natural sciences and engineering (72.100)

Founded
26 Jun 2015
Employees
11
Chief executive
Torstein Myhre
Business address
Strandveien 50, 1366 Lysaker

The life line 2015–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2026: NOK 131.5m.

  1. Chair took office§ 07
  2. Managing director took office§ 07
  3. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

ASCENSIA DIABETES CARE NORWAY AS is a private limited company in Bærum, founded in 2015, in the industry research and experimental development on natural sciences and engineering. The chief executive is Torstein Myhre, and the chair of the board is Torkild Sagberg Andersen. In 2026 the company had NOK 131.5m in operating revenue and a net profit of NOK 6.8m.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 22 Oct 2026

  • New industry code 46.46 → 72.1
  • New contact details
  • Changed purpose or activity
  • Endring av styre

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

None registered

None of the rules apply.The rules are fixed: bankruptcy, missing annual accounts, three years of losses, negative equity and the like. Checked 15 Nov 2026.

Overview

§ 03 Key figures

Revenue NOK 131.5m in 2026

Revenue

NOK 131.5m

+13.2% from 2025

20242026

Operating profit

NOK 8.9m

+6.7% from 2025

20242026

Net profit

NOK 6.8m

+4.8% from 2025

20242026

Equity

NOK 16.3m

+14.2% from 2025

20242026

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 26%
  • Depreciation 0%
  • Other operating costs 17%
  • Not specified in the source 50%
  • Left as operating result 7%

Of the net profit for 2025, NOK −5.1m stayed in the company. The rest, NOK 11.6m, is an assumed dividend.

The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 23.3%

RevenueNOK 131.5m Operating margin6.8% Equity ratio23.3% Revenue growth+13.2%
  • ASCENSIA DIABETES CARE NORWAY AS, 2026
  • Industry median, assumed: NOK 793k · 5.3% · 63.2% · −32.4%

Equity NOK 16.3m23% of the assets (NOK 69.8m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 68 companies in industry section M, not stated by the source.

Finances

§ 06 Accounts

11 years, latest 2026

NOK 1,0002024–26202620252024
Operating revenue131,541116,199110,706
Operating profit8,9038,3436,671
Profit before tax8,7668,3636,698
Net profit6,8336,5215,224
Total assets69,78155,39751,696
Equity16,27714,25019,333
Liabilities53,50541,14832,363

Source: the Register of Company Accounts, read 15 Nov 2026 · All 11 years →

Management and ownership

§ 07 Officers

8 officers now

The board: 3 members

Source: the Brønnøysund Register Centre, read 10 Nov 2026 · All 8 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

To styremedlemmer i fellesskap eller styrets leder alene.

May sign for the company:

To styremedlemmer i fellesskap eller styrets leder alene.

Power of procuration:

Daglig leder alene.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 2 Oct 2026

Management and ownership

§ 09 Owners

None registered

No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

1 connection

  • Person
  • Company

1 person links ASCENSIA DIABETES CARE NORWAY AS to 1 other companies: Torstein Myhre 1.

Source: the Brønnøysund Register Centre, read 10 Nov 2026 · Explore the network →

Events and registers

§ 13 Events

36 since 2015

Events per year

20152026

  • Notices30
  • Register changes6

Since 2015: 30 announcements and 6 register changes. Most happened in 2015 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 36 events →

Events and registers

§ 14 Notices

30, latest 20 Oct 2026

  • Styre
  • Godkjente årsregnskap
  • Godkjente årsregnskap

Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 30 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 9 Jul 2015
  • VATRegistered
  • The Register of Business EnterprisesRegistered 9 Jul 2015
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Utvikling, produksjon, markedsføring, salg og andre aktiviteter innen legemiddel- og helseindustrien, inkudert diagnostikkenheter og -tjenester, samt å drive enhver handling og aktivitet i tilknytning til og i formidnelse med dette.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 72.100

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

6 questions

  • Who is the chief executive of ASCENSIA DIABETES CARE NORWAY AS?
    Torstein Myhre, since 2016. § 07
  • What was the revenue in 2026?
    NOK 131.5m in the company. § 06
  • Who can sign for ASCENSIA DIABETES CARE NORWAY AS?
    To styremedlemmer i fellesskap eller styrets leder alene. § 08
  • Who is the auditor?
    KPMG AS, from 30 Dec 2015. § 07
  • Where is ASCENSIA DIABETES CARE NORWAY AS based?
    Strandveien 50, 1366 Lysaker.
  • When was ASCENSIA DIABETES CARE NORWAY AS founded?
    26 Jun 2015, registered in the Register of Business Enterprises 9 Jul 2015. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose